Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis

1
Myriad Genetics, Inc. (MYGN) - Product Pipeline
Analysis
Company Profiles and Conferences
2
Summary

• Myriad Genetics, Inc. (Myriad) is a molecular
  diagnostic company. The company undertakes the
  discovery and commercialization of molecular
  diagnostic tests that assesses persons risk
  towards disease development, disease progression
  and recurrence and guide through the treatment
  decisions. Its product portfolio iincludes nine
  commercial molecular diagnostic tests, namely,
  six predictive medicine tests one prognostic
  medicine test and two personalized medicine
  tests in the areas of oncology and CNS related
  disorders. Its commercial molecular diagnostic
  tests comprise BRACAnalysis, COLARIS, MELARIS,
  PANEXIA, COLARIS AP, PREZEON, TheraGuide,
  TruCulture, DiscoveryMAP, Prolaris and RodentMap
  The company along with its subsidiaries operates
  in the US, Spain, France, Switzerland, the UK,
  Canada, the Netherlands and Italy. The company is
  headquartered in Salt Lake City, Utah, the US.

Mob 919223375060 / 919223767111
3

• Scope
• The report reviews detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments
• The report analyzes all pipeline products in
  development for the company Myriad Genetics, Inc.
• The report provides pipeline analysis on all
  pipeline products of the company
• The report covers detailed information on each
  pipeline product with information on pipeline
  territory, stage of development, device class,
  regulatory path, indication(s), application(s)
  and estimated launch date

Mob 919223375060 / 919223767111
4

• Reasons to Buy
• Develop business strategies by understanding the
  trends and developments driving the medical
  devices pipeline and technology landscape
• Design and develop your product development,
  marketing and sales strategies by understanding
  the competitor portfolio
• To formulate effective RD strategies
• Develop market-entry and market expansion
  strategies
• Exploit in-licensing and out-licensing
  opportunities by identifying products, most
  likely to ensure a robust return
• Plan mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline
• - Identify emerging players with potentially
  strong product portfolio and create effective
  counter-strategies to gain competitive advantage

Mob 919223375060 / 919223767111
5
Table of Contents

• List of Figures
• Myriad Genetics, Inc. Company Snapshot
• Myriad Genetics, Inc. Company Overview
• Key Information
• Myriad Genetics, Inc. Pipeline Products and
  Clinical Trials Overview
• Myriad Genetics, Inc. Pipeline Analysis
  Overview
• Key Facts
• Myriad Genetics, Inc. - Major Products and
  Services
• Myriad Genetics, Inc. Pipeline Products by
  Development Stage

Mob 919223375060 / 919223767111
6
Custom Research

• There are times when you may not find the company
  profile of your choice in our database. If that
  is the case then you must go for customized
  research. Our multifarious capabilities,
  cross-sector expertise and detailed knowledge of
  various markets, put us at a unique position to
  take up Custom Research demands of the
  customers. 
• We provide the specifications of the custom
  research job to a dedicated team comprising of
  researchers, analysts and industry experts, who
  have close experience and understanding of global
  markets, competitive landscapes, various business
  models, market shares, drivers, restraints and
  benchmarks. The Custom Research is highly
  insightful and actionable. 

Mob 919223375060 / 919223767111
7
To know more Myriad Genetics, Inc. (MYGN) -
Product Pipeline Analysis

z

• Contact Us Mob 919223375060 /
  919223767111Fax [phone] Email id
  info_at_companyprofilesandconferences.com

www.companyprofilesandconferences.com